On Tuesday, the Biden administration announced that all prescription drug manufacturers representing the 10 medications selected for negotiation through Medicare under a newly enacted policy have agreed to take part in the process, which should formally begin early next year.
“Today I can announce that the manufacturers of ten drugs are coming to the negotiating table to lower prices,” President Joe Biden said in a statement. “They’re taking steps to participate in the negotiating program so we can give seniors the best possible deal.”
The 10 medications that were initially announced for negotiation last month account for 20 percent of Medicare Part D prescription costs. Four of the drugs are related to the treatment of diabetes, with the remainder treating ailments such as heart failure, psoriasis and arthritis, blood cancer, Crohn’s disease, and more.
More medications will be negotiated in the future, the administration said, and around 60 medications will be part of the program over the next four years.
Negotiation on prescription drug prices through Medicare was passed last year as part of the Inflation Reduction Act. Most Americans support the government having the ability to negotiate the costs of medication; a recent poll found that 76 percent back the idea, while only 6 percent said they opposed it.
Drug companies had until the start of this month to decide whether they’d take part in negotiations. While the companies involved in producing the drugs said they would cooperate with the process, many are still suing the administration, arguing that the policy is a violation of their constitutional rights.
However, the announcement from the White House comes just days after a federal judge in Ohio expressed skepticism of those claims. U.S. District Court Judge Michael Newman, a Trump administration appointee, refused a request from the U.S. Chamber of Commerce last week to place an injunction on the provision.
Newman appeared to disagree with the chamber’s arguments that the negotiation process interfered with a Fifth Amendment right to due process, as the judge noted there is no constitutional right to do business with the federal government. “Any economic harm — which, on its own, is insufficient to satisfy this prong of a preliminary injunction analysis — will not occur for years in the future,” Newman recognized.
The judge also said that the chamber “demonstrated neither a strong likelihood of success” in the lawsuit, “nor irreparable harm” from the law.
Advocates for fairer medication pricing lauded the initial ruling from Newman.
“This is the first major blow to Big Pharma in its legal battles to block the drug price negotiation provisions under the Inflation Reduction Act,” Peter Maybarduk, director of the Access to Medicines program at Public Citizen, said in a statement following the denial of the injunction request.
The negotiation process, however, will take some time. Negotiations won’t formally begin until February 2024 — and even after that, new drug prices won’t be implemented until 2026 at the earliest, assuming that none of the ongoing lawsuits delay the process in the meantime.
Truthout Is Preparing to Meet Trump’s Agenda With Resistance at Every Turn
Dear Truthout Community,
If you feel rage, despondency, confusion and deep fear today, you are not alone. We’re feeling it too. We are heartsick. Facing down Trump’s fascist agenda, we are desperately worried about the most vulnerable people among us, including our loved ones and everyone in the Truthout community, and our minds are racing a million miles a minute to try to map out all that needs to be done.
We must give ourselves space to grieve and feel our fear, feel our rage, and keep in the forefront of our mind the stark truth that millions of real human lives are on the line. And simultaneously, we’ve got to get to work, take stock of our resources, and prepare to throw ourselves full force into the movement.
Journalism is a linchpin of that movement. Even as we are reeling, we’re summoning up all the energy we can to face down what’s coming, because we know that one of the sharpest weapons against fascism is publishing the truth.
There are many terrifying planks to the Trump agenda, and we plan to devote ourselves to reporting thoroughly on each one and, crucially, covering the movements resisting them. We also recognize that Trump is a dire threat to journalism itself, and that we must take this seriously from the outset.
After the election, the four of us sat down to have some hard but necessary conversations about Truthout under a Trump presidency. How would we defend our publication from an avalanche of far right lawsuits that seek to bankrupt us? How would we keep our reporters safe if they need to cover outbreaks of political violence, or if they are targeted by authorities? How will we urgently produce the practical analysis, tools and movement coverage that you need right now — breaking through our normal routines to meet a terrifying moment in ways that best serve you?
It will be a tough, scary four years to produce social justice-driven journalism. We need to deliver news, strategy, liberatory ideas, tools and movement-sparking solutions with a force that we never have had to before. And at the same time, we desperately need to protect our ability to do so.
We know this is such a painful moment and donations may understandably be the last thing on your mind. But we must ask for your support, which is needed in a new and urgent way.
We promise we will kick into an even higher gear to give you truthful news that cuts against the disinformation and vitriol and hate and violence. We promise to publish analyses that will serve the needs of the movements we all rely on to survive the next four years, and even build for the future. We promise to be responsive, to recognize you as members of our community with a vital stake and voice in this work.
Please dig deep if you can, but a donation of any amount will be a truly meaningful and tangible action in this cataclysmic historical moment.
We’re with you. Let’s do all we can to move forward together.
With love, rage, and solidarity,
Maya, Negin, Saima, and Ziggy